Integration of Different “-omics” Technologies Identifies Inhibition of the IGF1R-Akt-mTOR Signaling Cascade Involved in the Cytotoxic Effect of Shikonin against Leukemia Cells
Hematological malignancies frequently have a poor prognosis and often remain incurable. Drug resistance, severe side effects, and relapse are major problems of currently used drugs, and new candidate compounds are required for improvement of therapy success. The naphthoquinone shikonin derived from...
Main Authors: | Wiench, Benjamin, Chen, Yet-Ran, Paulsen, Malte, Hamm, Rebecca, Schröder, Sven, Yang, Ning-Sun, Efferth, Thomas |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703888/ |
Similar Items
-
Shikonin Directly Targets Mitochondria and Causes Mitochondrial Dysfunction in Cancer Cells
by: Wiench, Benjamin, et al.
Published: (2012) -
The Paradox of Akt-mTOR Interactions
by: Vadlakonda, Lakshmipathi, et al.
Published: (2013) -
β-hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling
by: LU, DAN, et al.
Published: (2015) -
Akt and mTOR in B Cell Activation and Differentiation
by: Limon, Jose J., et al.
Published: (2012) -
Akt and mTOR mediate programmed necrosis in neurons
by: Liu, Q, et al.
Published: (2014)